According to a new study, psoriasis patients being treated with acitretin are at greater risk of developing psychiatric disorders compared to those receiving disease-modifying antirheumatic drugs (DMARDs).
PsO patients treated with methotrexate may have increased skin cancer risk
According to a new study, psoriasis patients treated with methotrexate are almost three times more likely to develop nonmelanoma skin cancer when compared to those not on methotrexate.
New study shows paucity of valuable HS patient education information on YouTube
A new study has shown a paucity of valuable patient education information regarding surgical or medical treatments for hidradenitis suppurativa (HS) on YouTube.
Psoriasis patients prioritize application feel, non-staining, quick absorption in topical treatment
According to a new study, psoriasis patients reported that application feel, non-staining quality and quick absorption were the most important factors in their preference of topical treatments and in ensuring treatment adherence.
New study shows guselkumab does not increase cancer risk in psoriasis patients
According to a recent study, guselkumab does not increase cancer risk in psoriasis (PsO) patients compared to general and psoriasis populations.
AD linked to higher risk of osteoarthritis
According to a recent study, individuals with atopic dermatitis (AD) and asthma may be more likely to develop osteoarthritis.
Risankizumab shows efficacy in improving plaque psoriasis
According to a recent press release, risankizumab has been shown to be efficacious and safe in patients with plaque psoriasis who have a suboptimal response to IL-17A inhibitors.
Sleep disturbances caused by AD improve over time
According to a new study, sleep disturbances in adults with moderate-to-severe atopic dermatitis (AD) generally improve over time.
Study shows childhood AD increased significantly in Black and multiracial children
New findings show that atopic dermatitis (AD) incidence and prevalence have increased over the last two decades, especially in Black and multiracial children.
Study shows no increased risk for serious infections in pediatric PsO patients on ustekinumab
According to a new study, there is no increased risk of infections in pediatric psoriasis (PsO) patients treated with ustekinumab compared to etanercept or methotrexate.
HealthMinute.TV 